Clinically important food-drug interactions: What the practitioner needs to know;Alle medikamente zum frühstück? - Einfluss der nahrung auf die medikamentenwirkung

Praxis

Volumn 101, Issue 13, 2012, Pages 849-855

  Corti, N ^a   Taegtmeyer, A B ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Food; Interactions; Medication

Indexed keywords

ALBENDAZOLE; ALCOHOL; BISPHOSPHONIC ACID DERIVATIVE; TYRAMINE;

FOOD COMPOSITION; FOOD DRUG INTERACTION; FOOD INTAKE; GRAPEFRUIT JUICE; HEALTH CARE PERSONNEL; HUMAN; SHORT SURVEY;

CIRCADIAN RHYTHM; DRUG CHRONOTHERAPY; DRUG THERAPY, COMBINATION; FOOD-DRUG INTERACTIONS; GENERAL PRACTICE; GERMANY; HUMANS; PHARMACOKINETICS; RISK FACTORS;

EID: 84862897760     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/1661-8157/a000978     Document Type: Short Survey

References (13)

1. Lange H, Eggers R, Bircher J: Increased systemic availability of albendazole when taken with a fatty meal. Eur J Clin Pharmacol 1988; 34: 315-317.
2. Ogunbona FA, Smith IF, Olawoye OS: Fat contents of meals and bioavailability of griseofulvin in man. J Pharm Pharmacol 1985; 37: 283-284. (Pubitemid 15149848)
3. Schmidt LE, Dalhoff K: Food-drug interactions. Drugs 2002; 62: 1481-1502. (Pubitemid 34804156)
4. Beatty SJ, Mehta BH, Rodis JL: Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets. Ann Pharmacother 2005; 39: 744-747. (Pubitemid 40396633)
5. Murray M: Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis. Curr Drug Metab 2006; 7: 67-81.
6. Soons PA, Vogels BA, Roosenalen MC, Schoemaker HC, Uchida E, Edgar B, et al.: Grapefruit juice and cimetidine inhibit stereoselective metabolismof nitrendipine in humans. Clin Pharmacol Ther 1991; 50: 394-403.
7. Lilja JJ, Neuvonen M, Neuvonen PJ: Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin. Br J Clin Pharmacol 2004; 58: 56-60. (Pubitemid 38901467)
8. Won CS, Oberlies NH, Paine MF: Influence of dietary substances on intestinal drug metabolism and transport. Curr Drug Metab 2010; 11: 778-792.
9. Riordan SM, Williams R: Alcohol exposure and paracetamol-induced hepatotoxicity. Addict Biol 2002; 7: 191-206. (Pubitemid 34492956)
10. Youdim MB, Edmondson D, Tipton KF: The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 2006; 7: 295-309.
11. Kaneko T, Ishigatsubo Y: Isoniazid and food interactions: fish, cheese, and wine. Intern Med 2005; 44: 1120-1121.
12. Self TH, Chrisman CR, Baciewicz AM, Bronze MS: Isoniazid drug and food interactions. Am J Med Sci 1999; 317: 304-311. (Pubitemid 30350425)
13. Di Gion P, Kanefendt F, Lindauer A, Scheffler M, Doroshyenko O, Fuhr U, et al.: Clinical pharmacokinetics of thyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles. Clin Pharmacokinet 2011;50: 551-603.